Cargando…

Identification of differentially expressed signatures of long non-coding RNAs associated with different metastatic potentials in gastric cancer

BACKGROUND: Gastric cancer (GC) is known for its lymph node metastasis and outstanding morbidity and mortality. Thus, improvement in the current knowledge regarding the molecular mechanism of GC is urgently needed to discover novel biomarkers involved in its progression and prognosis. Several long,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Song, Wu, Liu, Yu-yi, Peng, Jian-jun, Liang, Han-hui, Chen, Hua-yun, Chen, Jian-hui, He, Wei-ling, Xu, Jian-bo, Cai, Shi-rong, He, Yu-long
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Japan 2015
Materias:	Original Article—Alimentary Tract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4742487/ https://www.ncbi.nlm.nih.gov/pubmed/26045391 http://dx.doi.org/10.1007/s00535-015-1091-y

Ejemplares similares

Selective expansion of intraepithelial lymphocytes expressing the HLA-E–specific natural killer receptor CD94 in celiac disease()()
por: Jabri*, ‡, §, Bana, et al.
Publicado: (2000)

Clinical characteristics of coronavirus disease (COVID-19) patients with gastrointestinal symptoms: A report of 164 cases
por: Zhang, Hu, et al.
Publicado: (2020)

COVID-19 pandemic perception in adults with celiac disease: an impulse to implement the use of telemedicine
por: Siniscalchi, Monica, et al.
Publicado: (2020)

Impact of COVID-19 outbreak on clinical practice and training of young gastroenterologists: A European survey
por: Marasco, Giovanni, et al.
Publicado: (2020)

COVID-19 in IBD: The experience of a single tertiary IBD center
por: Rizzello, Fernando, et al.
Publicado: (2021)

Impact of the COVID-19 outbreak and the serum prevalence of SARS-CoV-2 antibodies in patients with inflammatory bowel disease treated with biologic drugs
por: Bossa, Fabrizio, et al.
Publicado: (2021)

Risk of COVID 19 in patients with inflammatory bowel diseases compared to a control population
por: Maconi, Giovanni, et al.
Publicado: (2021)

Maintaining standard volumes, efficacy and safety, of fecal microbiota transplantation for C. difficile infection during the COVID-19 pandemic: A prospective cohort study
por: Ianiro, Gianluca, et al.
Publicado: (2020)

Anti-SARS-CoV-2 immunoglobulin profile in patients with celiac disease living in a high incidence area
por: Elli, Luca, et al.
Publicado: (2022)

Impact of COVID-19 pandemic on the management of paediatric inflammatory bowel disease: An Italian multicentre study on behalf of the SIGENP IBD Group
por: Arrigo, Serena, et al.
Publicado: (2021)

Reduced humoral response to two doses of COVID-19 vaccine in patients with inflammatory bowel disease: Data from ESCAPE-IBD, an IG-IBD study
por: Macaluso, Fabio Salvatore, et al.
Publicado: (2023)

The natural history of COVID-19 in vaccinated inflammatory bowel disease patients
por: Viazis, N., et al.
Publicado: (2023)

Identification of anti-Helicobacter pylori antibody signatures in gastric intestinal metaplasia
por: Song, Lusheng, et al.
Publicado: (2022)

miR-324-3p promotes gastric cancer development by activating Smad4-mediated Wnt/beta-catenin signaling pathway
por: Sun, Guang-Li, et al.
Publicado: (2017)

Mucin Gene Deficiency in Mice Impairs Host Resistance to an Enteric Parasitic Infection
por: Hasnain, Sumaira Z., et al.
Publicado: (2010)

IL23R Variation Determines Susceptibility But Not Disease Phenotype in Inflammatory Bowel Disease
por: Tremelling, Mark, et al.
Publicado: (2007)

Tissue-Specific Amino Acid Transporter Partners ACE2 and Collectrin Differentially Interact With Hartnup Mutations
por: Camargo, Simone M.R., et al.
Publicado: (2009)

Attenuation of indomethacin-induced gastric mucosal injury by prophylactic administration of sake yeast-derived thioredoxin
por: Nakajima, Atsushi, et al.
Publicado: (2012)

Gastric epithelial neoplasm of fundic-gland mucosa lineage: proposal for a new classification in association with gastric adenocarcinoma of fundic-gland type
por: Ueyama, Hiroya, et al.
Publicado: (2021)

Profiling of circulating microRNAs in patients with Barrett’s esophagus and esophageal adenocarcinoma
por: Bus, Pauline, et al.
Publicado: (2015)

Mechanisms of curcumin-induced gastroprotection against ethanol-induced gastric mucosal lesions
por: Czekaj, Renata, et al.
Publicado: (2017)

Risk of gastric cancer in the second decade of follow-up after Helicobacter pylori eradication
por: Take, Susumu, et al.
Publicado: (2019)

Risk of gastric and oesophageal adenocarcinoma following discontinuation of long-term proton-pump inhibitor therapy
por: Holmberg, Dag, et al.
Publicado: (2022)

Genomic landscape of epithelium with low-grade atypia on gastric cancer after Helicobacter pylori eradiation therapy
por: Masuda, Kazuhiko, et al.
Publicado: (2019)

Aberrant methylation of microRNA-34b/c is a predictive marker of metachronous gastric cancer risk
por: Suzuki, Ryo, et al.
Publicado: (2013)

A gene expression profile related to immune dampening in the tumor microenvironment is associated with poor prognosis in gastric adenocarcinoma
por: Pasini, Fatima Solange, et al.
Publicado: (2013)

Clinical impact of intratumoral HER2 heterogeneity on trastuzumab efficacy in patients with HER2-positive gastric cancer
por: Wakatsuki, Takeru, et al.
Publicado: (2018)

The tumor-stromal ratio as a strong prognosticator for advanced gastric cancer patients: proposal of a new TSNM staging system
por: Peng, Chunwei, et al.
Publicado: (2017)

A novel role for the extracellular matrix glycoprotein‐Tenascin‐X in gastric function
por: Aktar, Rubina, et al.
Publicado: (2019)

Efficacy and Safety of Modified Dual Therapy as the First-line Regimen for the Treatment of Helicobacter pylori Infection: A Meta-Analysis of Randomized Controlled Trials
por: Huang, Qiuyue, et al.
Publicado: (2021)

Endoscopic evaluation by the Kyoto classification of gastritis combined with serum anti-Helicobacter pylori antibody testing reliably risk-stratifies subjects in a population-based gastric cancer screening program
por: Hirai, Ryosuke, et al.
Publicado: (2023)

Lansoprazole for secondary prevention of gastric or duodenal ulcers associated with long-term low-dose aspirin therapy: results of a prospective, multicenter, double-blind, randomized, double-dummy, active-controlled trial
por: Sugano, Kentaro, et al.
Publicado: (2011)

Medium-chain and long-chain fatty acids are associated with diarrheal predominant irritable bowel syndrome revealed by DESI-MSI
por: Zhang, Yanli, et al.
Publicado: (2023)

Dysbiosis of Gut Fungal Microbiota is Associated With Mucosal Inflammation in Crohn’s Disease
por: Li, Qiurong, et al.
Publicado: (2014)

Lansoprazole for secondary prevention of gastric or duodenal ulcers associated with long-term non-steroidal anti-inflammatory drug (NSAID) therapy: results of a prospective, multicenter, double-blind, randomized, double-dummy, active-controlled trial
por: Sugano, Kentaro, et al.
Publicado: (2012)

The identification of celiac disease in asymptomatic children: the Generation R Study
por: Jansen, Michelle, et al.
Publicado: (2017)

Impact of mindfulness tendency and physical activity on brain-gut interactions
por: Koseki, Tomonori, et al.
Publicado: (2023)

The clonal heterogeneity of colon cancer with liver metastases
por: Chen, Guanxuan, et al.
Publicado: (2023)

Novel Orally Administered Recombinant Anti-TNF Alpha Fusion Protein for the Treatment of Ulcerative Colitis: Results From a Phase 2a Clinical Trial
por: Almon, Einat, et al.
Publicado: (2021)

Current Practice and Perception of Screening for Medication Adherence in Inflammatory Bowel Disease
por: Trindade, Arvind J., et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_ltd5p3m2da2s5jt4lebs64ljv6